This COVID Stock Market Winner Is Making a Comeback, Up 125% Year to Date
Moderna stock is up 125.51% in 2026, driven by an FDA flu vaccine win, a corporate pivot, and an expanding pipeline. Here's what's moving MRNA.
Opent in een nieuw tabblad. Via Cryptopage meten we de klik voor statistieken.
Partner